CYTK – cytokinetics, incorporated (US:NASDAQ)
Stock Stats
News
Cytokinetics: Small Label Differences With Big Commercial Stakes [Seeking Alpha]
Cytokinetics (NASDAQ:CYTK) was given a new $84.00 price target on by analysts at Truist Financial Corporation.
Cytokinetics (NASDAQ:CYTK) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Cytokinetics (NASDAQ:CYTK) was given a new $83.00 price target on by analysts at Leerink Partners.
Cytokinetics, Incorporated (CYTK) Discusses FDA Approval of MYQORZO for Symptomatic Obstructive Hypertrophic Cardiomyopathy Transcript [Seeking Alpha]
Form 4 CYTOKINETICS INC For: Dec 22 Filed by: Blum Robert I
Form 4 CYTOKINETICS INC For: Dec 22 Filed by: WIERENGA WENDELL
Form 144 CYTOKINETICS INC Filed by: WIERENGA WENDELL
Form 8-K CYTOKINETICS INC For: Dec 19
Form 4 CYTOKINETICS INC For: Dec 16 Filed by: Malik Fady Ibraham
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.